跳至主要内容
临床试验/DRKS00031733
DRKS00031733招募中不适用

Applicability and specificity of optical coherence tomography as biomarker of dopaminergic neurodegeneration

Klinik für Neurologie0 个研究点目标入组 100 人开始时间: 2023年4月24日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
30 Years 至 80 Years(—)
性别
All

入选标准

  • Parkinson's syndrome or unclear tremor syndrome (which led to referral to nuclear medicine for FP-CIT SPECT examination).
  • Signing of the consent form

排除标准

  • - Non-consent or inability to consent to study participation.
  • - Alcohol/drug abuse (current or history)
  • - acute psychotic symptoms
  • - Relevant previous ophthalmologic disease (high-grade visual loss, age-related macular degeneration, glaucoma)
  • - relevant cognitive impairment (MOCA score < 18)
  • - severe previous internal disease (e.g. cardiac insufficiency) or orthopedic/rheumatologic previous disease interfering with the planned examinations
  • - Pregnancy according to self-disclosure

研究者

相似试验

Applicability and specificity of optical coherence... | 临床试验